Compare Royal Caribbean Cruises Ltd (RCL) vs ResMed Inc. (RMD) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Royal Caribbean Cruises Ltd vs ResMed Inc. — how do they compare? Royal Caribbean Cruises Ltd trades at $260.14 (market cap $70.74B), while ResMed Inc. trades at $219.5 (market cap $31.73B). The key difference: Royal Caribbean Cruises Ltd is far larger — about 2.2× ResMed Inc.'s market cap, and Royal Caribbean Cruises Ltd pays the higher dividend (2.27%). Which is the better fit depends on your goals.
| RCL | RMD | |
|---|---|---|
Market Cap | $70.74B | $31.73B |
Sector | Consumer Cyclical | Health |
52-Week High | $350.23 | $283.28 |
52-Week Low | $246.71 | $182.82 |
Enterprise Value | $93.38B | $31.08B |
Dividend Yield | 2.27% | 1.2% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Royal Caribbean (RCL) trades at $264.5, down 0.26% on the day, with a bearish technical signal from moving averages but bullish oscillators. The stock shows strong fundamentals with Q2 2026 EPS beating expectations at $4.21 versus $3.98, and robust profitability margins including a 23.54% net income margin. Recent news highlights dividend declarations and institutional buying interest, though oil price increases pose near-term headwinds for cruise operators.
The outlook remains positive with analyst consensus price target of $367.83 implying significant upside, supported by earnings growth and debt reduction trends. Key risks include fuel cost volatility from rising oil prices and macroeconomic sensitivity, but institutional accumulation and strong cash flows provide a solid foundation for long-term investors.
ResMed (RMD) trades at $221.05, down 3.2% on the day, with a bearish technical signal and key support at $218. The company reported strong Q4 2026 results, beating EPS estimates at $2.95, and maintains robust profitability with a 26.94% net income margin. Revenue growth remains solid, reaching $5.15B in 2025, though weak 2027 sales guidance has pressured the stock. A dividend of $0.66 is scheduled for payment in September 2026.
Outlook is mixed: strong fundamentals and a consensus price target of $235.70 suggest upside, but bearish technicals and investor lawsuits pose near-term risks. The stock offers value with a P/E of 21.19, yet competitive and regulatory challenges require monitoring for sustained growth.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Royal Caribbean Cruises Ltd
Royal Caribbean is the world's second-largest cruise company, operating 64 ships across five global and partner brands in the cruise vacation industry, with 10 more ships on order. Brands the company operates include Royal Caribbean International, Celebrity Cruises, and Silversea. The company also has a 50% investment in a joint venture that operates TUI Cruises and Hapag-Lloyd Cruises, allowing it to compete on the basis of innovation, quality of ships and service, variety of itineraries, choice of destinations, and price. The company completed the divestiture of its Azamara brand in the first quarter of 2021.
Read more on RCL →About ResMed Inc.
ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.
Read more on RMD →
